Rocket Pharmaceuticals (RCKT) Competitors $6.53 +0.62 (+10.49%) Closing price 04/15/2025 04:00 PM EasternExtended Trading$6.35 -0.18 (-2.76%) As of 09:23 AM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock RCKT vs. TWST, MIRM, VCEL, BHC, BHVN, TARS, GMTX, BLTE, AAPG, and NAMSShould you be buying Rocket Pharmaceuticals stock or one of its competitors? The main competitors of Rocket Pharmaceuticals include Twist Bioscience (TWST), Mirum Pharmaceuticals (MIRM), Vericel (VCEL), Bausch Health Companies (BHC), Biohaven (BHVN), Tarsus Pharmaceuticals (TARS), Gemini Therapeutics (GMTX), Belite Bio (BLTE), Ascentage Pharma Group International (AAPG), and NewAmsterdam Pharma (NAMS). These companies are all part of the "pharmaceutical products" industry. Rocket Pharmaceuticals vs. Twist Bioscience Mirum Pharmaceuticals Vericel Bausch Health Companies Biohaven Tarsus Pharmaceuticals Gemini Therapeutics Belite Bio Ascentage Pharma Group International NewAmsterdam Pharma Twist Bioscience (NASDAQ:TWST) and Rocket Pharmaceuticals (NASDAQ:RCKT) are both medical companies, but which is the better stock? We will contrast the two businesses based on the strength of their media sentiment, earnings, profitability, risk, community ranking, analyst recommendations, valuation, institutional ownership and dividends. Which has stronger earnings & valuation, TWST or RCKT? Twist Bioscience has higher revenue and earnings than Rocket Pharmaceuticals. Twist Bioscience is trading at a lower price-to-earnings ratio than Rocket Pharmaceuticals, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioTwist Bioscience$330.19M7.14-$208.73M-$3.38-11.69Rocket PharmaceuticalsN/AN/A-$245.60M-$2.73-2.39 Is TWST or RCKT more profitable? Rocket Pharmaceuticals has a net margin of 0.00% compared to Twist Bioscience's net margin of -59.76%. Twist Bioscience's return on equity of -32.69% beat Rocket Pharmaceuticals' return on equity.Company Net Margins Return on Equity Return on Assets Twist Bioscience-59.76% -32.69% -25.25% Rocket Pharmaceuticals N/A -62.62%-54.17% Does the media favor TWST or RCKT? In the previous week, Rocket Pharmaceuticals had 5 more articles in the media than Twist Bioscience. MarketBeat recorded 16 mentions for Rocket Pharmaceuticals and 11 mentions for Twist Bioscience. Twist Bioscience's average media sentiment score of 1.07 beat Rocket Pharmaceuticals' score of 0.95 indicating that Twist Bioscience is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Twist Bioscience 7 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 1 Negative mention(s) 0 Very Negative mention(s) Positive Rocket Pharmaceuticals 5 Very Positive mention(s) 2 Positive mention(s) 5 Neutral mention(s) 1 Negative mention(s) 0 Very Negative mention(s) Positive Which has more risk & volatility, TWST or RCKT? Twist Bioscience has a beta of 2.34, indicating that its share price is 134% more volatile than the S&P 500. Comparatively, Rocket Pharmaceuticals has a beta of 1, indicating that its share price has a similar volatility profile to the S&P 500. Does the MarketBeat Community prefer TWST or RCKT? Rocket Pharmaceuticals received 292 more outperform votes than Twist Bioscience when rated by MarketBeat users. Likewise, 73.38% of users gave Rocket Pharmaceuticals an outperform vote while only 58.99% of users gave Twist Bioscience an outperform vote. CompanyUnderperformOutperformTwist BioscienceOutperform Votes10558.99% Underperform Votes7341.01% Rocket PharmaceuticalsOutperform Votes39773.38% Underperform Votes14426.62% Do analysts prefer TWST or RCKT? Twist Bioscience currently has a consensus price target of $52.80, indicating a potential upside of 33.67%. Rocket Pharmaceuticals has a consensus price target of $43.00, indicating a potential upside of 558.50%. Given Rocket Pharmaceuticals' stronger consensus rating and higher probable upside, analysts plainly believe Rocket Pharmaceuticals is more favorable than Twist Bioscience.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Twist Bioscience 1 Sell rating(s) 1 Hold rating(s) 8 Buy rating(s) 0 Strong Buy rating(s) 2.70Rocket Pharmaceuticals 0 Sell rating(s) 1 Hold rating(s) 11 Buy rating(s) 0 Strong Buy rating(s) 2.92 Do insiders & institutionals believe in TWST or RCKT? 98.4% of Rocket Pharmaceuticals shares are owned by institutional investors. 3.0% of Twist Bioscience shares are owned by insiders. Comparatively, 28.5% of Rocket Pharmaceuticals shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company will outperform the market over the long term. SummaryRocket Pharmaceuticals beats Twist Bioscience on 11 of the 17 factors compared between the two stocks. Remove Ads Get Rocket Pharmaceuticals News Delivered to You Automatically Sign up to receive the latest news and ratings for RCKT and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart RCKT vs. The Competition Export to ExcelMetricRocket PharmaceuticalsPharmaceutical IndustryMedical SectorNASDAQ ExchangeMarket Cap$696.29M$6.33B$5.33B$7.57BDividend YieldN/A3.24%5.11%4.32%P/E Ratio-2.376.8121.7017.82Price / SalesN/A225.96377.7294.61Price / CashN/A65.6738.1534.64Price / Book1.205.866.464.00Net Income-$245.60M$141.86M$3.20B$247.23M7 Day Performance20.93%4.38%2.77%1.44%1 Month Performance-25.46%-12.76%-8.60%-6.26%1 Year Performance-73.07%-11.13%10.40%0.59% Rocket Pharmaceuticals Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)RCKTRocket Pharmaceuticals4.6217 of 5 stars$6.53+10.5%$43.00+558.5%-72.8%$696.29MN/A-2.37240Insider TradeNews CoverageGap UpHigh Trading VolumeTWSTTwist Bioscience3.4699 of 5 stars$36.99+2.2%$54.10+46.3%+35.1%$2.21B$330.19M-10.94990Positive NewsHigh Trading VolumeMIRMMirum Pharmaceuticals3.9566 of 5 stars$41.01-2.4%$58.20+41.9%+61.6%$2.01B$336.89M-20.30140Positive NewsVCELVericel2.4152 of 5 stars$39.90-4.8%$62.29+56.1%-13.7%$2.00B$237.22M665.11300News CoverageHigh Trading VolumeBHCBausch Health Companies4.0054 of 5 stars$5.26-1.4%$7.17+36.4%-47.6%$1.93B$9.63B-43.7919,900Short Interest ↑BHVNBiohaven3.4968 of 5 stars$17.86-3.9%$62.77+251.4%-58.5%$1.82BN/A-1.91239Analyst RevisionTARSTarsus Pharmaceuticals2.9532 of 5 stars$47.49+1.0%$63.67+34.1%+40.6%$1.82B$182.95M-12.4650Positive NewsGMTXGemini TherapeuticsN/A$41.22-9.9%N/A+26.5%$1.79BN/A-41.2230Gap DownHigh Trading VolumeBLTEBelite Bio2.8627 of 5 stars$55.80-1.9%$96.67+73.2%+61.8%$1.78BN/A-50.2710Short Interest ↓Analyst RevisionAAPGAscentage Pharma Group InternationalN/A$20.40-2.6%N/AN/A$1.78B$980.65M0.00600Positive NewsGap DownNAMSNewAmsterdam Pharma2.2585 of 5 stars$15.86+0.3%$43.33+173.2%-18.6%$1.74B$45.56M-6.104Short Interest ↑Gap DownHigh Trading Volume Remove Ads Related Companies and Tools Related Companies TWST Competitors MIRM Competitors VCEL Competitors BHC Competitors BHVN Competitors TARS Competitors GMTX Competitors BLTE Competitors AAPG Competitors NAMS Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:RCKT) was last updated on 4/16/2025 by MarketBeat.com Staff From Our PartnersCrypto’s crashing…but we’re still profitingMost traders are panicking right now. Bitcoin’s dropping. Altcoins are bleeding. The stock market’s a mess....Crypto Swap Profits | SponsoredREVEALED FREE: Our top 3 stocks to own in 2025 and beyondEvery time Weiss Ratings flashed green like this, the average gain on each and every stock has been 303% (incl...Weiss Ratings | SponsoredTariffs. Volatility. Fear. Here’s the Plan.Wall Street's panicking over tariffs. Volatility's back with a vengeance. If you've been glued to the he...Investors Alley | SponsoredMusk’s AI Masterplan – Our #1 AI Stock to Buy NowDid Elon Musk just set the stage for the next AI stock explosion? One 30-year Wall Street veteran thinks so...Behind the Markets | SponsoredTwo Unmistakable Patterns Return…The signs suggest we're entering one of those rare periods now. That's why Central Banks are buying gold at...Golden Portfolio | SponsoredWarning: “DOGE Collapse” imminentElon Strikes Back You may already sense that the tide is turning against Elon Musk and DOGE. Just this week...Altimetry | SponsoredMusk's panic move: What the world's richest man fears is comingWhether you have modest savings of $10,000 or substantial wealth of $10 million, this information could determ...InvestorPlace | SponsoredNew “Trump” currency proposed in DCAccording to one of the most connected men in Washington… A surprising new bill was just introduced in Wash...Paradigm Press | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Rocket Pharmaceuticals, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Rocket Pharmaceuticals With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy RCKT Stock Free RCKT Stock Alerts